









市場
/
株式
/
nasdaq-hrow
/

Harrow Inc

HROW

34.930USD

+3.560+11.35%

終値 07/11, 16:00（ET）15分遅れの株価

1.25B時価総額

損失額直近12ヶ月PER



Harrow Inc

34.930

+3.560+11.35%

概要企業名金融

Harrow, Inc. is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the North American market. The Company offers a comprehensive portfolio of prescription and non-prescription pharmaceutical products. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. It owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. It owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, ILEVRO, FLAREX, NATACYN, ZERVIATE, BYQLOVI and others. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms. IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3% is a low-viscosity gel indicated for ocular surface anesthesia.

企業情報

企業コードHROW

会社名Harrow Inc

上場日Feb 08, 2013

設立日2006

最高経営責任者「CEO」Mr. John P. Saharek

従業員数382

証券種類Ordinary Share

決算期末Feb 08

本社所在地1A Burton Hills Blvd

都市NASHVILLE

証券取引所NASDAQ Global Market Consolidated

国United States of America

郵便番号37215

電話番号16157334731

ウェブサイトhttps://www.harrow.com/

企業コードHROW

上場日Feb 08, 2013

設立日2006

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Mark L. Baum, J.D.

Chairman of the Board, Chief Executive Officer

2.60M

+21.61%

Mr. Andrew R. Boll

Chief Financial Officer, Corporate Secretary

777.84K

+36.92%

Mr. John P. Saharek

President and Chief Executive Officer of ImprimisRx

467.39K

+58.62%

Dr. Adrienne L. Graves, Ph.D.

Independent Director

Mrs. Lauren P. Silvernail

Independent Director

Mr. Perry J. Sternberg

Lead Independent Director

Mr. Amir Shojaei, Ph.D.

Chief Scientific Officer

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Mark L. Baum, J.D.

Chairman of the Board, Chief Executive Officer

2.60M

+21.61%

Mr. Andrew R. Boll

Chief Financial Officer, Corporate Secretary

777.84K

+36.92%

Mr. John P. Saharek

President and Chief Executive Officer of ImprimisRx

467.39K

+58.62%

Dr. Adrienne L. Graves, Ph.D.

Independent Director

Mrs. Lauren P. Silvernail

Independent Director

Mr. Perry J. Sternberg

Lead Independent Director

収益内訳

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Product Sales Net

47.74M

0.00%

Transfer of acquired product sales/profit

86.00K

0.00%

データなし

事業別

地域別

事業別USD

会社名

収益

比率

Product Sales Net

47.74M

0.00%

Transfer of acquired product sales/profit

86.00K

0.00%

株主

更新時刻: Fri, May 16

株主統計

種類

株主統計

比率

Opaleye Management Inc.

10.72%

Baum (Mark L)

7.08%

BlackRock Institutional Trust Company, N.A.

6.20%

Private Capital Management

5.15%

The Vanguard Group, Inc.

5.07%

Other

65.78%

株主統計

比率

Opaleye Management Inc.

10.72%

Baum (Mark L)

7.08%

BlackRock Institutional Trust Company, N.A.

6.20%

Private Capital Management

5.15%

The Vanguard Group, Inc.

5.07%

Other

65.78%

種類

株主統計

比率

Investment Advisor/Hedge Fund

23.15%

Hedge Fund

18.11%

Individual Investor

15.07%

Investment Advisor

12.93%

Research Firm

2.04%

Pension Fund

0.45%

Bank and Trust

0.33%

Sovereign Wealth Fund

0.07%

Insurance Company

0.03%

Other

27.83%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

340

26.58M

72.44%

-3.00M

2025Q1

354

25.78M

70.87%

-4.22M

2024Q4

350

26.13M

73.38%

-4.49M

2024Q3

325

25.90M

72.95%

-2.80M

2024Q2

296

24.70M

70.19%

-6.36M

2024Q1

284

26.34M

74.95%

-7.20M

2023Q4

279

28.26M

80.94%

-4.94M

2023Q3

275

28.51M

81.73%

-152.59K

2023Q2

265

25.64M

85.30%

+312.85K

2023Q1

246

23.86M

79.81%

+1.57M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Opaleye Management Inc.

3.94M

10.72%

-4.80K

-0.12%

Jun 04, 2025

Baum (Mark L)

2.60M

7.08%

+461.94K

+21.61%

Apr 21, 2025

BlackRock Institutional Trust Company, N.A.

2.27M

6.2%

-1.07K

-0.05%

Mar 31, 2025

Private Capital Management

1.89M

5.15%

+195.64K

+11.54%

Mar 31, 2025

The Vanguard Group, Inc.

1.86M

5.07%

-6.65K

-0.36%

Mar 31, 2025

Kaufman (Daniel)

1.68M

4.59%

-222.91K

-11.69%

Aug 12, 2024

Braidwell LP

956.84K

2.61%

+49.80K

+5.49%

Mar 31, 2025

State Street Global Advisors (US)

786.48K

2.14%

-41.22K

-4.98%

Mar 31, 2025

Boll (Andrew R)

777.84K

2.12%

+209.75K

+36.92%

Apr 21, 2025

Geode Capital Management, L.L.C.

774.08K

2.11%

+52.97K

+7.35%

Mar 31, 2025

詳細を見る